Page last updated: 2024-08-26

hecogenin and Experimental Mammary Neoplasms

hecogenin has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebrahim, HY; El Sayed, KA; Elsayed, HE; Haggag, EG; Kamal, AM1

Other Studies

1 other study(ies) available for hecogenin and Experimental Mammary Neoplasms

ArticleYear
Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies.
    Bioorganic & medicinal chemistry, 2017, 12-15, Volume: 25, Issue:24

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Mammary Neoplasms, Experimental; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Molecular Structure; Protein Kinase Inhibitors; Sapogenins; Structure-Activity Relationship; Thiosemicarbazones; Tumor Cells, Cultured

2017